Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Lysosomes01:31

Lysosomes

27.3K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
27.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.7K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.7K
Glucose Transporters01:27

Glucose Transporters

28.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

HKDC1 contributes to aberrant lysosome-mitochondria contact in Niemann-Pick disease type C.

bioRxiv : the preprint server for biology·2026
Same author

Erratum to "Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids" [Pharmacological Reviews 78 (2026) 100113].

Pharmacological reviews·2026
Same author

Synthesis of N-Acetyl-D- and -L-Leucine-<sup>13</sup>C<sub>6</sub> Tool Compounds in Neurodegenerative Disease.

ChemMedChem·2026
Same author

Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids.

Pharmacological reviews·2026
Same author

Molecular and biochemical insights into dysregulation of glycosphingolipid metabolism in a mouse model of lysosomal free sialic acid storage disorder.

Experimental neurology·2026
Same author

Limited therapeutic efficacy of N-acetyl-L-leucine in a mouse model of CLN1 disease.

Scientific reports·2025

Video Experimental Relacionado

Updated: Apr 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.7K

Trastornos del almacenamiento lisosómico de esfingolipidos.

Frances M Platt1

  • 1Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

Nature
|June 6, 2014
PubMed
Resumen
Este resumen es generado por máquina.

Las enfermedades de almacenamiento lisosomal son trastornos metabólicos genéticos causados por la acumulación de macromoléculas. La investigación sobre estas condiciones raras, en particular el almacenamiento de glucosfingolipidos, avanza en la biología celular y el desarrollo de terapias.

Más Videos Relacionados

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.7K
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

Videos de Experimentos Relacionados

Last Updated: Apr 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.7K
Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.7K
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

Área de la Ciencia:

  • La bioquímica es la bioquímica.
  • Genética La genética.
  • Biología celular Biología celular.

Sus antecedentes:

  • Las enfermedades de almacenamiento lisosomal (LSD) son errores congénitos del metabolismo caracterizados por la acumulación de macromoléculas en el sistema endocítico tardío.
  • Estos trastornos monogénicos ocurren colectivamente en 1 de cada 5.000 nacidos vivos, derivados de defectos hereditarios en los genes que codifican las proteínas lisosomales, principalmente enzimas.
  • Un subconjunto específico involucra el almacenamiento lisosomal de los glucosfingolipidos.

Objetivo del estudio:

  • Aclarar aspectos fundamentales de la biología celular a través del estudio de los trastornos de almacenamiento de esfingolipidos.
  • Para resaltar los avances terapéuticos en las enfermedades de almacenamiento lisosomal.
  • Explorar las conexiones emergentes entre los LSD y las enfermedades comunes.

Principales métodos:

  • Análisis genético de trastornos monogénicos.
  • Investigación bioquímica de las vías metabólicas.
  • Estudios celulares centrados en el sistema endocítrico tardío.

Principales resultados:

  • La comprensión de los trastornos de almacenamiento de esfingolipidos ha proporcionado una visión crítica de la biología celular fundamental.
  • Se han logrado avances significativos en el desarrollo de terapias para LSDs, con varios ahora en uso clínico.
  • Se están descubriendo nuevos vínculos mecánicos entre los LSD y las enfermedades más comunes.

Conclusiones:

  • El estudio de las enfermedades de almacenamiento lisosomal ofrece profundos conocimientos sobre la biología celular básica y los mecanismos de la enfermedad.
  • Las estrategias terapéuticas para los LSD han avanzado considerablemente, mejorando los resultados de los pacientes.
  • Los límites entre los trastornos genéticos raros y las enfermedades comunes pueden necesitar una reevaluación debido a los mecanismos subyacentes compartidos.